In favor of a potential anti-inflammatory role, mmu-miR-27b-3p was demonstrated to target PPAR-γ mRNA, and thereby to attenuate PPAR-γ-mediated NF-κB activation in neuroblastoma cells (Lee et al., 2012). This evidence concerns the gene NFKB1 and neuroblastoma.